OR6C2: A Potential Drug Target and Biomarker (G341416)

OR6C2: A Potential Drug Target and Biomarker

OR6C2 (OR6C2_HUMAN), a protein that belongs to the OR6C2 family, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. OR6C2 is a cytoplasmic protein that is expressed in most tissues of the human body and is involved in various cellular processes, including cell adhesion, migration, and signaling pathways.

The OR6C2 protein is composed of 214 amino acid residues and has a calculated molecular weight of 21.9 kDa. OR6C2 is a single-pass transmembrane protein that functions as a receptor for various signaling molecules, including TGF-β, Wnt, and Notch. OR6C2 is also known to play a role in cell-cell adhesion and has been shown to be involved in the regulation of cell migration and the development of various tissues, including neural cells and cancer cells.

OR6C2 has been shown to be involved in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, OR6C2 has been shown to be involved in the development and progression of various types of cancer, including breast, ovarian, and colorectal cancers. OR6C2 has also been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, and has been shown to play a role in the regulation of immune responses.

In addition to its potential involvement in disease, OR6C2 has also been shown to be a potential drug target. OR6C2 has been shown to be involved in the regulation of cellular signaling pathways and has been shown to interact with various signaling molecules, including TGF-β, Wnt, and Notch. This suggests that OR6C2 may be a useful target for small molecules that can modulate these signaling pathways and potentially have therapeutic effects on a variety of diseases.

One potential approach to targeting OR6C2 as a drug target is to use small molecules that can modulate its activity. For example, researchers have shown that inhibitors of the OR6C2 receptor can inhibit the migration and invasion of cancer cells, suggesting that these inhibitors may be effective in targeting cancer cells. Additionally, researchers have shown that inhibitors of OR6C2 can protect against neurodegenerative diseases, suggesting that these inhibitors may be effective in protecting against these conditions.

Another potential approach to targeting OR6C2 as a drug target is to use small molecules that can modulate its expression. For example, researchers have shown that small molecules can be used to increase the expression of OR6C2, suggesting that these molecules may be effective in increasing the production of OR6C2 and potentially increasing its levels in the body.

Overall, OR6C2 is a protein that has been shown to be involved in various cellular processes and has been identified as a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of OR6C2 in disease and to develop effective treatments for these conditions.

Protein Name: Olfactory Receptor Family 6 Subfamily C Member 2

Functions: Odorant receptor

The "OR6C2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR6C2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1 | OR9Q2